Neurodex: Phase II data; Phase III for pseudobulbar effect

In an open-label, dose-escalation U.S. Phase II trial in 36 patients, Neurodex-treated patients had

Read the full 141 word article

How to gain access

Continue reading with a
two-week free trial.